» Articles » PMID: 25900066

Impulsivity and Aggression in Schizophrenia: a Neural Circuitry Perspective with Implications for Treatment

Overview
Journal CNS Spectr
Specialties Neurology
Psychiatry
Date 2015 Apr 23
PMID 25900066
Citations 31
Authors
Affiliations
Soon will be listed here.
Abstract

Elevations of impulsive behavior have been observed in a number of serious mental illnesses. These phenomena can lead to harmful behaviors, including violence, and thus represent a serious public health concern. Such violence is often a reason for psychiatric hospitalization, and it often leads to prolonged hospital stays, suffering by patients and their victims, and increased stigmatization. Despite the attention paid to violence, little is understood about its neural basis in schizophrenia. On a psychological level, aggression in schizophrenia has been primarily attributed to psychotic symptoms, desires for instrumental gain, or impulsive responses to perceived personal slights. Often, multiple attributions can coexist during a single aggressive incident. In this review, I discuss the neural circuitry associated with impulsivity and aggression in schizophrenia, with an emphasis on implications for treatment. Impulsivity appears to account for a great deal of aggression in schizophrenia, especially in inpatient settings. Urgency, defined as impulsivity in the context of strong emotion, is the primary focus of this article. It is elevated in several psychiatric disorders, and in schizophrenia, it has been related to aggression. Many studies have implicated dysfunctional frontotemporal circuitry in impulsivity and aggression in schizophrenia, and pharmacological treatments may act via that circuitry to reduce urgency and aggressive behaviors; however, more mechanistic studies are critically needed. Recent studies point toward manipulable neurobehavioral targets and suggest that cognitive, pharmacological, neuromodulatory, and neurofeedback treatment approaches can be developed to ameliorate urgency and aggression in schizophrenia. It is hoped that these approaches will improve treatment efficacy.

Citing Articles

Metabolic pathway modulation by olanzapine: Multitarget approach for treating violent aggression in patients with schizophrenia.

Song Y, Xia S, Sun Z, Chen Y, Jiao L, Wan W World J Psychiatry. 2025; 15(1):101186.

PMID: 39831024 PMC: 11684224. DOI: 10.5498/wjp.v15.i1.101186.


The study on agitation and structure of orbitofrontal cortex subregion in first-episode drug-naïve patients with schizophrenia.

Dong Y, Chen C, Li Y, Cao P, Tang Y, Xu G Brain Imaging Behav. 2024; 19(1):175-188.

PMID: 39661320 DOI: 10.1007/s11682-024-00961-z.


On the effects of impulsivity and compulsivity on neural correlates of model-based performance.

Duck K, Wullhorst R, Overmeyer R, Endrass T Sci Rep. 2024; 14(1):21057.

PMID: 39256477 PMC: 11387645. DOI: 10.1038/s41598-024-71692-w.


Aberrant glutamatergic systems underlying impulsive behaviors: Insights from clinical and preclinical research.

Yates J Prog Neuropsychopharmacol Biol Psychiatry. 2024; 135:111107.

PMID: 39098647 PMC: 11409449. DOI: 10.1016/j.pnpbp.2024.111107.


Emotion-related impulsivity and suicidal ideation and behavior in schizophrenia spectrum disorder: a pilot fMRI study.

Hoptman M, Evans K, Parincu Z, Sparpana A, Sullivan E, Ahmed A Front Psychiatry. 2024; 15:1408083.

PMID: 38988737 PMC: 11234166. DOI: 10.3389/fpsyt.2024.1408083.


References
1.
Ruiz S, Lee S, Soekadar S, Caria A, Veit R, Kircher T . Acquired self-control of insula cortex modulates emotion recognition and brain network connectivity in schizophrenia. Hum Brain Mapp. 2011; 34(1):200-12. PMC: 6869886. DOI: 10.1002/hbm.21427. View

2.
Cyders M, Smith G . Emotion-based dispositions to rash action: positive and negative urgency. Psychol Bull. 2008; 134(6):807-28. PMC: 2705930. DOI: 10.1037/a0013341. View

3.
Perry Y, Henry J, Nangle M, Grisham J . Regulation of negative affect in schizophrenia: the effectiveness of acceptance versus reappraisal and suppression. J Clin Exp Neuropsychol. 2012; 34(5):497-508. DOI: 10.1080/13803395.2012.661405. View

4.
Hoptman M, Volavka J, Czobor P, Gerig G, Chakos M, Blocher J . Aggression and quantitative MRI measures of caudate in patients with chronic schizophrenia or schizoaffective disorder. J Neuropsychiatry Clin Neurosci. 2006; 18(4):509-15. PMC: 1933590. DOI: 10.1176/jnp.2006.18.4.509. View

5.
Volkow N, Tancredi L, Grant C, Gillespie H, Valentine A, Mullani N . Brain glucose metabolism in violent psychiatric patients: a preliminary study. Psychiatry Res. 1995; 61(4):243-53. DOI: 10.1016/0925-4927(95)02671-j. View